Bloomage BioTechnology Corporation Limited (SHA:688363)
45.05
+0.28 (0.63%)
Mar 10, 2026, 11:15 AM CST
SHA:688363 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 21,416 | 20,895 | 24,416 | 32,239 | 65,081 | 74,544 | Upgrade
|
| Market Cap Growth | -8.78% | -14.42% | -24.27% | -50.46% | -12.69% | 6.06% | Upgrade
|
| Enterprise Value | 20,950 | 20,429 | 24,211 | 31,288 | 63,593 | 73,055 | Upgrade
|
| Last Close Price | 44.77 | 43.68 | 50.93 | 66.39 | 133.30 | 152.44 | Upgrade
|
| PE Ratio | 73.39 | 71.79 | 140.10 | 54.41 | 67.03 | 95.28 | Upgrade
|
| Forward PE | 37.47 | 38.61 | 34.88 | 29.56 | 51.50 | 90.88 | Upgrade
|
| PS Ratio | 5.08 | 4.96 | 4.55 | 5.31 | 10.23 | 15.07 | Upgrade
|
| PB Ratio | 3.02 | 2.95 | 3.57 | 4.62 | 9.74 | 13.07 | Upgrade
|
| P/TBV Ratio | 3.37 | 3.28 | 3.97 | 5.20 | 11.01 | 14.43 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 151.56 | Upgrade
|
| P/OCF Ratio | - | - | 43.25 | 46.08 | 102.46 | 58.42 | Upgrade
|
| PEG Ratio | - | 1.22 | 1.22 | 1.22 | 1.35 | 15.81 | Upgrade
|
| EV/Sales Ratio | 4.97 | 4.85 | 4.51 | 5.15 | 10.00 | 14.77 | Upgrade
|
| EV/EBITDA Ratio | 36.95 | 36.03 | 52.02 | 40.35 | 56.57 | 84.27 | Upgrade
|
| EV/EBIT Ratio | 62.74 | 61.18 | 104.19 | 54.87 | 66.14 | 97.87 | Upgrade
|
| EV/FCF Ratio | - | - | - | - | - | 148.53 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.05 | 0.03 | 0.06 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.41 | 0.41 | 0.68 | 0.25 | 0.33 | 0.33 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 0.61 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.07 | -0.06 | -0.16 | -0.26 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.87 | -0.87 | -0.84 | -1.42 | -1.55 | -2.71 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 2.48 | 3.33 | 28.54 | -4.78 | Upgrade
|
| Asset Turnover | - | - | 0.63 | 0.71 | 0.79 | 0.75 | Upgrade
|
| Inventory Turnover | - | - | 1.24 | 1.45 | 1.59 | 1.89 | Upgrade
|
| Quick Ratio | - | - | 1.00 | 1.47 | 1.61 | 2.20 | Upgrade
|
| Current Ratio | - | - | 2.04 | 2.56 | 2.45 | 2.85 | Upgrade
|
| Return on Equity (ROE) | 4.18% | 4.18% | 2.44% | 8.53% | 15.52% | 14.47% | Upgrade
|
| Return on Assets (ROA) | - | - | 1.70% | 4.15% | 7.42% | 7.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.42% | 4.46% | 2.97% | 8.75% | 19.64% | 20.72% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 3.20% | 7.90% | 13.70% | 12.20% | Upgrade
|
| Earnings Yield | 1.36% | 1.39% | 0.71% | 1.84% | 1.49% | 1.05% | Upgrade
|
| FCF Yield | - | - | -0.64% | -1.03% | -0.09% | 0.66% | Upgrade
|
| Dividend Yield | 0.24% | - | 0.22% | 0.57% | 0.46% | 0.32% | Upgrade
|
| Payout Ratio | 18.03% | - | 106.69% | 51.55% | 25.01% | 25.69% | Upgrade
|
| Buyback Yield / Dilution | 1.43% | 1.43% | -0.48% | 0.27% | -0.03% | -0.95% | Upgrade
|
| Total Shareholder Return | 1.67% | 1.43% | -0.27% | 0.84% | 0.43% | -0.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.